Tudor Investment Corp
ELVN icon

Tudor Investment Corp’s Enliven Therapeutics ELVN Stock Holding History

Tudor Investment Corp’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,673
Closed -$457K – 3897
2025
Q4 		$457K Buy
29,673
+13,370
+82% +$266K ﹤0.01% 2770
2025
Q3 		$334K Buy
+16,303
New +$329K ﹤0.01% 2917
2025
Q2 		– Sell
-13,363
Closed -$263K – 3500
2025
Q1 		$263K Buy
+13,363
New +$288K ﹤0.01% 2683
2024
Q3 		– Sell
-24,221
Closed -$566K – 2873
2024
Q2 		$566K Buy
+24,221
New +$510K 0.01% 1750
2022
Q4 		– Sell
-6,126
Closed -$56K – 2552
2022
Q3 		$56K Sell
6,126
-6,847
-53% -$40.4K ﹤0.01% 2183
2022
Q2 		$63K Sell
12,973
-8
-0.1% -$39 ﹤0.01% 1949
2022
Q1 		$98K Hold
12,981
– – ﹤0.01% 1836
2021
Q4 		$117K Hold
12,981
– – ﹤0.01% 2221
2021
Q3 		$212K Buy
+12,981
New +$270K ﹤0.01% 2273

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return